Results 51 to 60 of about 57,421 (320)
Risk for acromegaly-related comorbidities by sex in Korean acromegaly.
Journal of Clinical Endocrinology and Metabolism, 2020 CONTEXT Reports on the incidence, characteristics, and comorbidity in Asian patients with acromegaly are scarce. OBJECTIVE To evaluate the incidence of acromegaly and risk of comorbidities in East Asia, especially South Korea.
K. Park, Eun Jig Lee, G. Seo, C. Ku
semanticscholar +1 more source
Reproductive Biology and Endocrinology, 2023 Background Acromegaly is a disease of growth hormone excess that results in enlargement of extremities, abnormal glucose and lipid metabolism, and gonadal disruption. Manifestations of the disease are insidious and typically lead to a diagnostic delay of
Anamil M. Khiyami +6 more
doaj +1 more source
PituitaryPurpose A series of consensus guidelines on medical treatment of acromegaly have been produced in the last two decades. However, little information is available on their application in clinical practice. Furthermore, international standards of acromegaly
Acromegaly · Octreotide +21 more
semanticscholar +1 more source
Pregnancy and acromegaly [PDF]
Pituitary, 2016 Acromegaly is a rare disorder in which, due to the high incidence of secondary hypogonadism, pregnancies are relatively rare. However, some women with acromegaly do get pregnant, which brings along questions about medication, complications and follow-up.
Ammar Muhammad +2 more
openaire +4 more sources
Parathyroid localization [PDF]
, 1986 Twenty-nine consecutive patients with suspected primary hyperparathyroidism were examined preoperatively using ultrasound, sonographically guided fine needle aspiration, and aspirate immunostaining for PTH.
Borisch, B. +7 more
core +1 more source
Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly
International Journal of Endocrinology, 2020 Background. Asprosin is a novel identified adipokine secreted mainly by white adipose tissue, which is elevated in metabolic diseases such as diabetes and obesity.
Xiaoan Ke +8 more
doaj +1 more source
Clinical characteristics and efficacy of acromegaly treatment in the Udmurt Republic
Alʹmanah Kliničeskoj Mediciny, 2022 Background: Acromegaly is a severe neuroendocrine disorder caused by chronic overproduction of growth hormone and insulin-like growth factor 1 and associated with a variety of clinical manifestations, debilitating complications and progressive disability,
Guzel M. Nurullina +3 more
doaj +1 more source
Bromocriptine-associated ototoxicity [PDF]
, 2007 Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus
Ballantyne, J, Lanthier, PL, Morgan, MY
core +1 more source
Prevalence of acromegaly in patients with symptoms of sleep apnea.
PLoS ONE, 2017 Acromegaly is a rare disease with nonspecific symptoms with acral enlargement being almost universally present at diagnosis. The estimated prevalence is 40-125 cases/million but targeted universal screening studies have found a higher prevalence (about ...
Gemma Sesmilo +14 more
doaj +1 more source